Canine immune-mediated hemolytic anemia: treatment and prognosis.
The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.